CureMatch Articles & News
Scientists from CureMatch and UCSD use pharmacophore-based drug design and a molecular docking technique to identify candidate protease inhibitors for COVID-19 SAN DIEGO, CA – April 15, 2020 – CureMatch, a digital health company focusing on personalized medicine and combination therapies, today announced that Chief Science Officer and Co-Founder, Dr. Igor Tsigelny, along with Dr. […]
Oncology is currently the largest area of clinical health expenditures for prescription drugs in the United States [1], and, based on the current pace of innovation in cancer care, anti-cancer treatment costs are only expected to increase [2]. Still, cancer remains a significant medical challenge, stubbornly resistant to conventional treatments. Further, many patients with cancer […]
Navid Alipour, founder of our parent company, Analytics Ventures, was interviewed by AI Trends regarding the challenges of using artificial intelligence in healthcare–and how we at CureMatch are working to solve those challenges. Read the full article here.
CureMatch is pleased to announce our win at MedTech Insight Awards 2019 in the category of Best Technological Innovation: Digital. The judges explained their choice by describing the platform as “An exciting technology that has the potential to transform how cancer care is delivered. What an excellent use of data, and a well-deserved winning entry […]
CureMatch is pleased to announce our recent nomination for two innovation awards. MedTech announced that CureMatch is nominated for Best Technological Innovation: Diagnostics and Best Technological Innovation: Digital in their 2019 Insight Awards. The award ceremony will be held September 23 in Boston, Massachusetts, during the MedTech conference, hosted by AdvaMed. This valuable annual conference […]